The Elusive Payoff of Gain of Function Research
Experiments that make viruses more virulent or contagious present significant risks. Are those risks worth the rewards?
COVID-19
Gain-of-Function Research: All in the Eye of the Beholder
Should work done on coronaviruses in Wuhan, China, be considered “gain-of-function” research? Opinions differ.
Bad Blood? The Uncertainty Around Microclots and Long Covid
Scientists are debating whether microscopic blood clots are responsible for the wide range of symptoms in long Covid.
Why COVID Vaccines for Young Children Have Been Hard to Get
Access to pediatric COVID vaccines has been hampered by a shortage of doses, higher costs to providers and parental skepticism
A Valuable COVID Drug Doesn’t Work against New Variants
Current monoclonal antibodies fail against COVID virus variants, so drugmakers want to use a fast-track test for new ones
Omicron-Specific COVID Boosters Are Coming
The FDA has called for updating COVID vaccines to address the Omicron subvariants BA.4 and BA.5. But will the shots keep up with the virus?